Publications by authors named "Tarja Vihtamaki"

Article Synopsis
  • - The study examined the link between dietary fiber intake, lifestyle factors, and bowel function in relation to nausea or vomiting in pregnancy (NVP), finding that women with NVP consumed more fiber from cereal products and had increased total fiber intake in early pregnancy compared to those without NVP.
  • - Despite the higher fiber consumption among women experiencing NVP, dietary fiber did not prove to be protective against the symptoms; however, those with NVP managed to maintain their fiber intake throughout early pregnancy.
  • - The research suggests that dietary fiber is well-tolerated during NVP, indicating its potential role in diet counseling for pregnant women facing these symptoms, despite the unknowns surrounding the causes of NVP.
View Article and Find Full Text PDF

Objective: To compare ospemifene and raloxifene regarding their effects on hormones, lipids, genital tract, and tolerability in postmenopausal women.

Design: A randomized, double-blind study in which 118 healthy postmenopausal women received 30 (n = 29), 60 (n = 30), or 90 mg (n = 30) of ospemifene or 60 mg (n = 29) of raloxifene for 3 months.

Results: There were no significant differences in the baseline characteristics between study groups.

View Article and Find Full Text PDF

Objectives: To study the consequence of skin contamination by oestradiol gel on circulating plasma oestradiol levels.

Methods: We studied ten healthy, hysterectomized postmenopausal women who had used percutaneous oestradiol gel for at least 2 years. After wash-out period percutaneous dose of 1.

View Article and Find Full Text PDF

Objectives: To study the possible interaction between ascorbic acid (AA) and oestradiol (E2) in postmenopausal women on hormone replacement therapy (HRT).

Methods: We studied 25 healthy postmenopausal women who had used percutaneous E2 gel at same dose for 10-12 months, at which time the plasma E2 concentrations were stabilized. The subjects were treated with 1000 mg of AA daily for 3 months and blood samples for assay of AA and E2 were taken at 0, 1 and 3 months.

View Article and Find Full Text PDF

Objective: The purpose of the present study was to evaluate the hormonal profile of patients of postmenopausal age during estrogen replacement therapy (ERT) with special reference to the serum levels of biologically active FSH (B-FSH) in a self-adjusted ERT model.

Design: The hormonal values found have been correlated to climateric symptoms reported by the patients (scored by the Kupperman menopausal index (KI)).

Methods: B-FSH was measured using an assay based on a cell system transfected permanently with FSH receptor cDNA.

View Article and Find Full Text PDF